Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T B Horvath

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Psychiatry Research|December 1, 1984
Positive and negative symptoms in schizophreniaW G Rosen, R C Mohs, C A Johns, et al.
Journal of the American Geriatrics Society|November 1, 1985
Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studiesB M Davis, R C Mohs, B S Greenwald, et al.
Psychopharmacology Bulletin|October 1, 1980
Human memory and the effects of physostigmine and choline chloride [proceedings]K L Davis, R C Mohs, B M Davis, et al.
Journal of the American Geriatrics Society|November 1, 1985
Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studiesR C Mohs, B M Davis, B S Greenwald, et al.
The American Journal of Psychiatry|January 1, 1985
Oral physostigmine treatment of patients with Alzheimer's diseaseR C Mohs, B M Davis, C A Johns, et al.
Biological Psychiatry|February 1, 1984
A study of the reliability of reported premorbid adjustment in schizophrenic patientsN E Small, R C Mohs, R Halperin, et al.
Science (New York, N.Y.)|March 29, 1985
Plasma homovanillic acid concentration and the severity of schizophrenic illnessK L Davis, M Davidson, R C Mohs, et al.
Archives of General Psychiatry|May 1, 1984
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responsesM I Levy, B M Davis, R C Mohs, et al.
Psychopharmacology Bulletin|January 1, 1988
Kraepelinian schizophrenia: a subgroup of schizophrenia?R S Keefe, R C Mohs, M Davidson, et al.
Psychiatry Research|July 28, 1995
Lateral ventricular enlargement in schizotypal personality disorderL J Siever, M Rotter, M Losonczy, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Psychiatry Research|December 1, 1984
Positive and negative symptoms in schizophreniaW G Rosen, R C Mohs, C A Johns, et al.
Journal of the American Geriatrics Society|November 1, 1985
Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studiesB M Davis, R C Mohs, B S Greenwald, et al.
Psychopharmacology Bulletin|October 1, 1980
Human memory and the effects of physostigmine and choline chloride [proceedings]K L Davis, R C Mohs, B M Davis, et al.
Journal of the American Geriatrics Society|November 1, 1985
Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studiesR C Mohs, B M Davis, B S Greenwald, et al.
The American Journal of Psychiatry|January 1, 1985
Oral physostigmine treatment of patients with Alzheimer's diseaseR C Mohs, B M Davis, C A Johns, et al.
Biological Psychiatry|February 1, 1984
A study of the reliability of reported premorbid adjustment in schizophrenic patientsN E Small, R C Mohs, R Halperin, et al.
Science (New York, N.Y.)|March 29, 1985
Plasma homovanillic acid concentration and the severity of schizophrenic illnessK L Davis, M Davidson, R C Mohs, et al.
Archives of General Psychiatry|May 1, 1984
Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responsesM I Levy, B M Davis, R C Mohs, et al.
Psychopharmacology Bulletin|January 1, 1988
Kraepelinian schizophrenia: a subgroup of schizophrenia?R S Keefe, R C Mohs, M Davidson, et al.
Psychiatry Research|July 28, 1995
Lateral ventricular enlargement in schizotypal personality disorderL J Siever, M Rotter, M Losonczy, et al.
Pageof 5